Radius Health, Inc.

NasdaqGM:RDUS Lagerbericht

Marktkapitalisierung: US$480.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Radius Health Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

G. Martin

Geschäftsführender

US$3.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts17.2%
Amtszeit als Geschäftsführer2.3yrs
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managementsless than a year
Durchschnittliche Amtszeit der Vorstandsmitglieder6.8yrs

Jüngste Management Updates

Recent updates

Radius Recycling: An Attractive, But Volatile, Play On A Cleaner Future

Jun 03

Radius stock rises as elacestrant gets FDA priority review to treat breast cancer subtype

Aug 11

Reevaluating Radius Health

Feb 24

Radius Health EPS misses by $0.02, misses on revenue

May 07

When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?

Feb 23
When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?

Revisiting Radius Health

Feb 01

Radius Health acquires global rights to RAD011 in Prader-Willi syndrome

Jan 06

How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 01
How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?

Radius Health on-track for record quarterly revenue for TYMLOS-SC

Dec 15

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von G. Martin im Vergleich zu den Einnahmen von Radius Health verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2022n/an/a

-US$69m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$3mUS$600k

-US$70m

Sep 30 2021n/an/a

-US$76m

Jun 30 2021n/an/a

-US$60m

Mar 31 2021n/an/a

-US$87m

Dec 31 2020US$12mUS$413k

-US$109m

Vergütung im Vergleich zum Markt: G.'s total compensation ($USD3.49M) is above average for companies of similar size in the US market ($USD2.61M).

Entschädigung vs. Einkommen: G.'s compensation has been consistent with company performance over the past year.

Geschäftsführer

G. Martin (63 yo)

2.3yrs

Amtszeit

US$3,493,881

Vergütung

Mr. G. Kelly Martin has been Executive Chairman of Wren Therapeutics Ltd. since 2018. Mr. Martin serves as the Chief Executive Officer, President and Director at Radius Health, Inc. since April 28, 2020.H...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
G. Martin
CEO, President & Director2.3yrsUS$3.49mkeine Daten
Danielle Holtschlag
VP of Sales & Head of U.S. Sales Channelsless than a yearUS$741.78kkeine Daten
Chhaya Shah
Senior VP & Chief Business Officer2.2yrsUS$1.22m0.27%
$ 1.3m
Stavros Manolagas
Founder & Member of the Scientific Advisory Boardno datakeine Datenkeine Daten
John Potts
Founder & Member of the Scientific Advisory Boardno datakeine Datenkeine Daten
Michael Rosenblatt
Founderno datakeine Datenkeine Daten
John Katzenellenbogen
Founder & Member of the Scientific Advisory Boardno datakeine Datenkeine Daten
Mark Conley
VP, CFOless than a yearkeine Datenkeine Daten
Peter Schwartzman
Head of Corporate Financeno datakeine Datenkeine Daten
Ethan Holdaway
Head of Investor Relationsless than a yearkeine Datenkeine Daten
Kim Clarke
General Counselless than a yearkeine Datenkeine Daten
Rohan Lathia
Head of Corporate & Business Developmentless than a yearkeine Datenkeine Daten

0.8yrs

Durchschnittliche Betriebszugehörigkeit

61.5yo

Durchschnittliches Alter

Erfahrenes Management: RDUS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
G. Martin
CEO, President & Director2.3yrsUS$3.49mkeine Daten
Stavros Manolagas
Founder & Member of the Scientific Advisory Boardno datakeine Datenkeine Daten
John Potts
Founder & Member of the Scientific Advisory Boardno datakeine Datenkeine Daten
Michael Rosenblatt
Founderno datakeine Datenkeine Daten
John Katzenellenbogen
Founder & Member of the Scientific Advisory Boardno datakeine Datenkeine Daten
Jean-Pierre Garnier
Independent Director6.7yrsUS$544.81k0.045%
$ 215.1k
Sean Murphy
Independent Director2yrsUS$534.84k0.012%
$ 55.5k
Willard Dere
Independent Director7.8yrsUS$536.69k0.037%
$ 178.7k
Cecil Richard Lyttle
Chairman of Scientific Advisory Board10.5yrsUS$30.00kkeine Daten
Owen Hughes
Independent Chairman9.3yrsUS$832.23k0.034%
$ 163.1k
Catherine Friedman
Independent Director7yrsUS$556.41k0.045%
$ 215.1k
Gary Hattersley
Member of Scientific Advisory Board3.8yrsUS$1.94mkeine Daten

6.8yrs

Durchschnittliche Betriebszugehörigkeit

68.5yo

Durchschnittliches Alter

Erfahrener Vorstand: RDUS's board of directors are considered experienced (6.8 years average tenure).